TIMI 31

TIMI 31 evaluated the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST-elevation myocardial infarction.

Screenshot_2021-02-03 No Slide Title - timi-31-slides pdf

MAIN RESULTS:
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial
TIMI 31
J Thromb Thrombolysis. 2006 Aug;22(1):13-21.

PRESENTATIONS

TIMI 31 Slides

search previous next tag category expand menu location phone mail time cart zoom edit close